Skip to main content

Animations

MJFF Publications

4851 - 4860 of 6255 Results
Title
Year
  • Year
  • 2022
  • 2023
  • 2020
  • 2024
  • 2023
  • 2017
  • 2022
  • 2021
  • 2018
  • 2021
  • Summary Details
    OPEN
    Title: How Vacations Affect Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13597
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson’s disease
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-023-37464-2
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Increased iron-deposition in lateral-ventral substantia nigra pars compacta: A promising neuroimaging marker for Parkinson's disease
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2020.102391
    Citation Count: 34
  • Summary Details
    OPEN
    Title: A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awae346
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Differential serum microRNAs in premotor LRRK2 G2019S carriers from Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00451-x
    Citation Count: 10
  • Summary Details
    OPEN
    Title: GBA mutations in Parkinson disease: earlier death but similar neuropathological features
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ene.13395
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity
    Journal Name: Brain Pathology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1111/bpa.13130
    Citation Count: 3
  • Summary Details
    OPEN
    Title: High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-021-01282-8
    Citation Count: 185
  • Summary Details
    OPEN
    Title: Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4)
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-181434
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Predicting optimal deep brain stimulation parameters for Parkinson’s disease using functional MRI and machine learning
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-021-23311-9
    Citation Count: 224
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.